Medical miscellany

n/

Developing Priorities for the Great Northern Landscape Conservation Cooperative: State Wildlife Action Plans (SWAP) as One Piece of Information

Landscape Conservation Cooperatives (LCCs) are public-private partnerships that focus on natural resource challenges which transcend political and jurisdictional boundaries and require a more holistic, collaborative, and adaptive approach to conservation that is firmly grounded in science and strives to ensure the sustainability of land, water, wildlife and cultural resources. The Great Northern LCC, covering Western Montana and parts of several other states and provinces, is nearing completion of a process that synthesizes conservation priorities among the 25 organizations represented on the Steering Committee and their partners. This Strategic Conservation Framework identifies priority species, ecosystems, and ecosystem processes across the landscape represented by the Great Northern LCC based on synthetic summarizations of five state-based Wildlife Action Plans, 40 other regional conservation planning documents, and focused interviews with key personnel across the region. Here we report on the process by which we analyzed data from the State Wildlife Action Plans (SWAPs) of ID, MT, OR, WA, and WY and from Strategic Habitat Conservation as one piece of information for strategic planning. Thirty-five species of greatest conservation need (as defined in the SWAPs) were identified as having commonality across the five states. The ranges of these species were then overlain and a map of areas with the greatest number of species of conservation need can be visualized across the Great Northern LCC

Midwife led randomised controlled trials in Australia and New Zealand: A scoping review

Background: Midwives are the largest workforce involved in caring for pregnant women and their babies, and are well placed to translate research into practice and ensure midwifery priorities are appropriately targeted in researched. Currently, the number and focus of randomised controlled trials led by midwives in Australia and New Zealand is unknown. The Australasian Nursing and Midwifery Clinical Trials Network was established in 2020 to build nursing and midwifery research capacity. To aid this, scoping reviews of the quality and quantity of nurse and midwife led trials were undertaken. Aim: To identify midwife led trials conducted between 2000 and 2021 in Australia and New Zealand. Methods: This review was informed by the JBI scoping review framework. Medline, Emcare, and Scopus were searched from 2000-August 2021. ANZCTR, NHMRC, MRFF, and HRC (NZ) registries were searched from inception to July 2021. Findings: Of 26,467 randomised controlled trials registered on the Australian and New Zealand Clinical Trials Registry, 50 midwife led trials, and 35 peer-reviewed publications were identified. Publications were of moderate to high quality with scores limited due to an inability to blind participants or clinicians. Blinding of assessors was included in 19 published trials. Discussion: Additional support for midwives to design and conduct trials and publish findings is required. Further support is needed to translate registration of trial protocols into peer reviewed publications. Conclusion: These findings will inform the Australasian Nursing and Midwifery Clinical Trials Network plans to promote quality midwife led trials

Harnessing the nursing and midwifery workforce to boost Australia\u27s clinical research impact

For the Medical Research Future Fund (MRFF) to achieve its full impact, it is necessary for health practitioners to be trained and reliably funded to deliver research and translation alongside their clinical work. We offer insight into current systems, concerns and suggestions as this applies to clinical research in nursing and midwifery. Nurses and midwives globally have a long record of delivering high quality clinical research that improves care and outcomes. An analysis of four landmark nursing-led studies in the United States illustrates the value-adding potential of such research: for every grant dollar, the return on investment ranged from $202 to$1206. In Australia, investment in nursing- and midwifery-led research also pays dividends for health care costs and population and health system outcomes, as evidenced from the many research contributions of Australian nurses and midwives over the past decade (Box)

The Nuclear Spectroscopic Telescope Array (NuSTAR)

The Nuclear Spectroscopic Telescope Array (NuSTAR) is a NASA Small Explorer mission that will carry the first focusing hard X-ray (5 -- 80 keV) telescope to orbit. NuSTAR will offer a factor 50 -- 100 sensitivity improvement compared to previous collimated or coded mask imagers that have operated in this energy band. In addition, NuSTAR provides sub-arcminute imaging with good spectral resolution over a 12-arcminute field of view. After launch, NuSTAR will carry out a two-year primary science mission that focuses on four key programs: studying the evolution of massive black holes through surveys carried out in fields with excellent multiwavelength coverage, understanding the population of compact objects and the nature of the massive black hole in the center of the Milky Way, constraining explosion dynamics and nucleosynthesis in supernovae, and probing the nature of particle acceleration in relativistic jets in active galactic nuclei. A number of additional observations will be included in the primary mission, and a guest observer program will be proposed for an extended mission to expand the range of scientific targets. The payload consists of two co-aligned depth-graded multilayer coated grazing incidence optics focused onto solid state CdZnTe pixel detectors. To be launched in early 2012 on a Pegasus rocket into a low-inclination Earth orbit. Data will be publicly available at GSFC's High Energy Astrophysics Science Archive Research Center (HEASARC) following validation at the science operations center located at Caltech.Comment: 9 pages, 5 figures, to appear in Proceedings of the SPIE, Space Telescopes and Instrumentation 2010: Ultraviolet to Gamma Ra

What does Life-Cycle Assessment of agricultural products need for more meaningful inclusion of biodiversity?

peer-reviewedDecision‐makers increasingly use life‐cycle assessment (LCA) as a tool to measure the environmental sustainability of products. LCA is of particular importance in globalized agricultural supply chains, which have environmental effects in multiple and spatially dispersed locations. Incorporation of impacts on biodiversity that arise from agricultural production systems into environmental assessment methods is an emerging area of work in LCA, and current approaches have limitations, including the need for (i) improved assessment of impacts to biodiversity associated with agricultural production, (ii) inclusion of new biodiversity indicators (e.g. conservation value, functional diversity, ecosystem services) and (iii) inclusion of previously unaccounted modelling variables that go beyond land‐use impacts (e.g. climate change, water and soil quality). Synthesis and applications. Ecological models and understanding can contribute to address the limitations of current life‐cycle assessment (LCA) methods in agricultural production systems and to make them more ecologically relevant. This will be necessary to ensure that biodiversity is not neglected in decision‐making that relies on LCA

Antibody interference and response kinetics of isatuximab plus pomalidomide and dexamethasone in multiple myeloma

The ICARIA-MM study was sponsored by Sanofi. The authors thank, Helgi van de Velde, Valérie Boutet, Shujia Dai, Deborah DiNoto, Graziella Engelvin, Olivier Fedeli, Sébastien Hugla, Dominique Mouret, Béatrice Pradeilles, and Alain Roccon, all employees of Sanofi, for their contribution to the study, technology, and comments on the manuscript. The authors thank the participating patients and their families, and the study centers and investigators, for their contributions to the study. The medical writing support was provided by John Clarke, PhD and Stephanie Brillhart, PhD of Elevate Medical Affairs, contracted by Sanofi Genzyme for publication support services

3C 273 with NuSTAR: Unveiling the Active Galactic Nucleus

We present results from a 244 ks NuSTAR observation of 3C 273 obtained during a cross-calibration campaign with the Chandra, INTEGRAL, Suzaku, Swift, and XMM-Newton observatories. We show that the spectrum, when fit with a power-law model using data from all observatories except INTEGRAL over the 1–78 keV band, leaves significant residuals in the NuSTAR data between 30 and 78 keV. The NuSTAR 3–78 keV spectrum is well described by an exponentially cutoff power law (Γ = 1.646 ± 0.006, E_(cutoff) = 202_(-34)^(+51) keV) with a weak reflection component from cold, dense material. There is also evidence for a weak (EW = 23 ± 11 eV) neutral iron line. We interpret these features as arising from coronal emission plus reflection off an accretion disk or distant material. Beyond 80 keV INTEGRAL data show clear excess flux relative to an extrapolation of the active galactic nucleus model fit to NuSTAR. This high-energy power law is consistent with the presence of a beamed jet, which begins to dominate over emission from the inner accretion flow at 30–40 keV. Modeling the jet locally (in the NuSTAR + INTEGRAL band) as a power law, we find that the coronal component is fit by Γ_(AGN) = 1.638 ± 0.045, E_(cutoff) = 47 ± 15 keV, and jet photon index by Γ_(jet) = 1.05 ± 0.4. We also consider Fermi/LAT observations of 3C 273, and here the broadband spectrum of the jet can be described by a log-parabolic model, peaking at ~2 MeV. Finally, we investigate the spectral variability in the NuSTAR band and find an inverse correlation between flux and Γ

The Nuclear Spectroscopic Telescope Array (NuSTAR)

The Nuclear Spectroscopic Telescope Array (NuSTAR) is a NASA Small Explorer mission that will carry the first focusing hard X-ray (5 - 80 keV) telescope to orbit. NuSTAR will offer a factor 50 - 100 sensitivity improvement compared to previous collimated or coded mask imagers that have operated in this energy band. In addition, NuSTAR provides sub-arcminute imaging with good spectral resolution over a 12-arcminute field of view. After launch, NuSTAR will carry out a two-year primary science mission that focuses on four key programs: studying the evolution of massive black holes through surveys carried out in fields with excellent multiwavelength coverage, understanding the population of compact objects and the nature of the massive black hole in the center of the Milky Way, constraining explosion dynamics and nucleosynthesis in supernovae, and probing the nature of particle acceleration in relativistic jets in active galactic nuclei. A number of additional observations will be included in the primary mission, and a. guest observer program will be proposed for an extended mission to expand the range of scientific targets. The payload consists of two co-aligned depth-graded multilayer coated grazing incidence optics focused onto solid state CdZnTe pixel detectors. To be launched in early 2012 on a Pegasus rocket into a low-inclination Earth orbit. NuSTAR largely avoids SAA passages, and will therefore have low and stable detector backgrounds. The telescope achieves a 10.15-meter focal length through on-orbit deployment of all mast. An aspect and alignment metrology system enable reconstruction of the absolute aspect and variations in the telescope alignment resulting from mast flexure during ground data processing. Data will be publicly available at GSFC's High Energy Astrophysics Science Archive Research Center (HEASARC) following validation at the science operations center located at Caltech